Abeona Therapeutics appoints Edward Carr as CFO, effective August 10, 2021

ABEONA THERAPEUTICS INC.

Edward Carr, previously CAO, becomes CFO; continues as principal financial officer.
Base salary of $400,000; annual bonus target of 40% of base salary.
Receives 238,000 restricted stock units and options for 476,000 shares (10-year term).
RSUs and options vest 25% on first anniversary, remainder over 36 months.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Edward Carr

Senior Vice President, Chief Financial Officer

ABEO · ABEONA THERAPEUTICS INC.

Effective: 2021-08-10
Filed: August 13, 2021, 7:59 PM ET

appointed Edward Carr, the Company’s Chief Accounting Officer, as Senior Vice President, Chief Financial Officer, effective on that same date.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Edward Carr was appointed as Senior Vice President, Chief Financial Officer at ABEONA THERAPEUTICS INC..

Action: appointed
Role: Senior Vice President, Chief Financial Officer

Exact text from the filing

appointed Edward Carr, the Company’s Chief Accounting Officer, as Senior Vice President, Chief Financial Officer, effective on that same date.

View on SEC.gov

ABEONA THERAPEUTICS INC. filing history →

Source: SEC EDGAR

accession 0001493152-21-019797

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.